Joint Formulary & PAD

Levocarnitine - Carnitine deficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Intravenous injection (IV)
Associated Icons :
BNF SPC
NFD1
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levocarnitine
Indication :
Carnitine deficiency in haemodialysis
Group Name :
Keywords :
Haemodialysis, L-carnitine, metabolic disorders
Brand Names Include :
Important Information :

NHSE specialised commissioned services only. Not commissioned from any acute Trust in Surrey Heartlands.
L-carnitine / levocarnitine in valproate toxicity has a separate formulary entry.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Levocarnitine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Carnitine deficiency in haemodialysis.

  • No records returned.

Committee Recommendations (0)

  • No records returned.